Machine Learning Revealed a Novel Ferroptosis-Based Classification for Diagnosis in Antiretroviral Therapy-Treated HIV Patients with Defective Immune Recovery
Restricted accessResearch articleFirst published online February, 2024
Machine Learning Revealed a Novel Ferroptosis-Based Classification for Diagnosis in Antiretroviral Therapy-Treated HIV Patients with Defective Immune Recovery
Despite virological suppression, the CD4+ T lymphocytes are not restored in some HIV-infected patients after antiretroviral therapy. These individuals are known as immune non-responders (INRs). INRs are at high risk of developing AIDS and non-AIDS-related events and have a shorter life expectancy. Hence, it is vital to identify INRs early and prevent their complications, but there are still no specific diagnostic indicators or models. Ferroptosis has lately been reported as a type of programmed cell death, which plays an indispensable part in diverse diseases. However, its particular regulatory mechanisms remain unclear and its function in the pathogenic process of defective immunological recovery is still unknown. Blood is mainly used for rapid diagnosis because it enables quick testing. To investigate the role of ferroptosis-related genes (FRGs) in early detection of INRs, we scrutinized Gene Expression Omnibus datasets of peripheral blood samples to estimate their effectiveness. To our knowledge, for the first time, gene expression data were utilized in this study to discover six FRGs that were explicitly expressed in peripheral blood from INRs. Later on, multiple machine-supervised learning algorithms were employed, and a superlative diagnostic model for INRs was built with the random forest algorithm, which displayed satisfactory diagnostic efficiency in the training cohort (area under the curve [AUC] = 0.99) and one external validation cohort (AUC = 0.727). Our findings suggest that FRGs are implicated in the development of defective immune recovery, presenting a potential route for early detection and potential biological targets for the most effective treatment of defective immune recovery.
Get full access to this article
View all access options for this article.
References
1.
YangX, SuB, ZhangX, et al.Incomplete immune reconstitution in HIV/AIDS patients on antiretroviral therapy: Challenges of immunological non-responders. J Leukoc Biol, 2020; 107(4):597–612; doi: 10.1002/jlb.4mr1019-189r
SeretiI, SheikhV, ShafferD, et al.Prospective international study of incidence and predictors of immune reconstitution inflammatory syndrome and death in people living with human immunodeficiency virus and severe lymphopenia. Clin Infect Dis, 2020; 71(3):652–660; doi: 10.1093/cid/ciz877
4.
BattegayM, NüeschR, HirschelB, et al.Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis, 2006; 6(5):280–287; doi: 10.1016/s1473-3099(06)70463-7
5.
XiaoQ, YuF, YanL, et al.Alterations in circulating markers in HIV/AIDS patients with poor immune reconstitution: Novel insights from microbial translocation and innate immunity. Front Immunol, 2022; 13:1026070; doi: 10.3389/fimmu.2022.1026070
6.
CorbeauP, ReynesJ. Immune reconstitution under antiretroviral therapy: The new challenge in HIV-1 infection. Blood, 2011; 117(21):5582–5590; doi: 10.1182/blood-2010-12-322453
7.
DixonSJ, LembergKM, LamprechtMR, et al.Ferroptosis: An iron-dependent form of nonapoptotic cell death. Cell, 2012; 149(5):1060–1072; doi: 10.1016/j.cell.2012.03.042
8.
YangWS, StockwellBR. Ferroptosis: Death by lipid peroxidation. Trends Cell Biol, 2016; 26(3):165–176; doi: 10.1016/j.tcb.2015.10.014
9.
StockwellBR, JiangX, GuW. Emerging mechanisms and disease relevance of ferroptosis. Trends Cell Biol, 2020; 30(6):478–490; doi: 10.1016/j.tcb.2020.02.009
10.
LeiG, ZhangY, KoppulaP, et al.The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression. Cell Res, 2020; 30(2):146–162; doi: 10.1038/s41422-019-0263-3
11.
LiaoP, WangW, WangW, et al.CD8(+) T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4. Cancer Cell, 2022; 40(4):365.e6–378.e6; doi: 10.1016/j.ccell.2022.02.003
12.
LiuJ, ZhangC, WangJ, et al.The regulation of ferroptosis by tumor suppressor p53 and its pathway. Int J Mol Sci, 2020; 21(21):8387; doi: 10.3390/ijms21218387
13.
XiaoQ, YanL, HanJ, et al.Metabolism-dependent ferroptosis promotes mitochondrial dysfunction and inflammation in CD4(+) T lymphocytes in HIV-infected immune non-responders. EBioMedicine, 2022; 86:104382; doi: 10.1016/j.ebiom.2022.104382
14.
WangW, GreenM, ChoiJE, et al.CD8(+) T cells regulate tumour ferroptosis during cancer immunotherapy. Nature, 2019; 569(7755):270–274; doi: 10.1038/s41586-019-1170-y
15.
SferaA, ThomasKG, AndronescuCV, et al.Bromodomains in human-immunodeficiency virus-associated neurocognitive disorders: A model of ferroptosis-induced neurodegeneration. Front Neurosci, 2022; 16:904816; doi: 10.3389/fnins.2022.904816
16.
CaoD, KhanalS, WangL, et al.A matter of life or death: Productively infected and bystander CD4 T cells in early HIV infection. Front Immunol, 2020; 11:626431; doi: 10.3389/fimmu.2020.626431
17.
ZhouN, BaoJ. FerrDb: A manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxford), 2020; 2020:baaa021; doi: 10.1093/database/baaa021
18.
StockwellBR, Friedmann AngeliJP, BayirH, et al.Ferroptosis: A regulated cell death nexus linking metabolism, redox biology, and disease. Cell, 2017; 171(2):273–285; doi: 10.1016/j.cell.2017.09.021
19.
BebberCM, MüllerF, Prieto ClementeL, et al.Ferroptosis in cancer cell biology. Cancers (Basel), 2020; 12(1):164; doi: 10.3390/cancers12010164
20.
HassanniaB, VandenabeeleP, Vanden BergheT. Targeting ferroptosis to iron out cancer. Cancer Cell, 2019; 35(6):830–849; doi: 10.1016/j.ccell.2019.04.002
21.
DaiC, ChenX, LiJ, et al.Transcription factors in ferroptotic cell death. Cancer Gene Ther, 2020; 27(9):645–656; doi: 10.1038/s41417-020-0170-2
22.
YounesSA, TallaA, Pereira RibeiroS, et al.Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunction. J Clin Invest, 2018; 128(11):5083–5094; doi: 10.1172/jci120245
23.
XiaY, MiF, DuG, et al.Analysis of protective immune responses to seasonal influenza vaccination in HIV-infected individuals. Hum Vaccin Immunother, 2021; 17(1):124–132; doi: 10.1080/21645515.2020.1754701
24.
BenferhatR, MartinonF, KrustB, et al.The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope. Mol Immunol, 2009; 46(4):705–712; doi: 10.1016/j.molimm.2008.10.001
25.
PowellAM, LuoZ, MartinL, et al.The induction of CD80 and apoptosis on B cells and CD40L in CD4+ T cells in response to seasonal influenza vaccination distinguishes responders versus non-responders in healthy controls and aviremic ART-treated HIV-infected individuals. Vaccine, 2017; 35(5):831–841; doi: 10.1016/j.vaccine.2016.12.026
26.
MassanellaM, NegredoE, Pérez-AlvarezN, et al.CD4 T-cell hyperactivation and susceptibility to cell death determine poor CD4 T-cell recovery during suppressive HAART. AIDS, 2010; 24(7):959–968; doi: 10.1097/QAD.0b013e328337b957
27.
XiaoQ, HanJ, YuF, et al.Elucidating the gene signatures and immune cell types in HIV-infected immunological non-responders by bioinformatics analyses. Int J Gen Med, 2022; 15:8491–8507; doi: 10.2147/ijgm.s390642
GaschlerMM, StockwellBR. Lipid peroxidation in cell death. Biochem Biophys Res Commun, 2017; 482(3):419–425; doi: 10.1016/j.bbrc.2016.10.086
30.
WangMP, JoshuaB, JinNY, et al.Ferroptosis in viral infection: The unexplored possibility. Acta Pharmacol Sin, 2022; 43:1905–1915; doi: 10.1038/s41401-021-00814-1
31.
ChenJ, LiX, GeC, et al.The multifaceted role of ferroptosis in liver disease. Cell Death Differ, 2022; 29(3):467–480; doi: 10.1038/s41418-022-00941-0
32.
ZhaoL, ZhouX, XieF, et al.Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond), 2022; 42(2):88–116; doi: 10.1002/cac2.12250
33.
XuX, LinD, TuS, et al.Is ferroptosis a future direction in exploring cryptococcal meningitis?. Front Immunol, 2021; 12:598601; doi: 10.3389/fimmu.2021.598601
34.
LedermanMM, CalabreseL, FunderburgNT, et al.Immunologic failure despite suppressive antiretroviral therapy is related to activation and turnover of memory CD4 cells. J Infect Dis, 2011; 204(8):1217–1226; doi: 10.1093/infdis/jir507
35.
NgiamKY, KhorIW. Big data and machine learning algorithms for health-care delivery. Lancet Oncol, 2019; 20(5):e262–e273; doi: 10.1016/s1470-2045(19)30149-4
36.
DeoRC. Machine learning in medicine. Circulation, 2015; 132(20):1920–1930; doi: 10.1161/circulationaha.115.001593
37.
CurrieG, HawkKE, RohrenE, et al.Machine learning and deep learning in medical imaging: Intelligent imaging. J Med Imaging Radiat Sci, 2019; 50(4):477–487; doi: 10.1016/j.jmir.2019.09.005
38.
KilicA. Artificial intelligence and machine learning in cardiovascular health care. Ann Thorac Surg, 2020; 109(5):1323–1329; doi: 10.1016/j.athoracsur.2019.09.042
39.
VamathevanJ, ClarkD, CzodrowskiP, et al.Applications of machine learning in drug discovery and development. Nat Rev Drug Discov, 2019; 18(6):463–477; doi: 10.1038/s41573-019-0024-5
40.
IssaNT, StathiasV, SchürerS, et al.Machine and deep learning approaches for cancer drug repurposing. Semin Cancer Biol, 2021; 68:132–142; doi: 10.1016/j.semcancer.2019.12.011
41.
GouldMK, HuangBZ, TammemagiMC, et al.Machine learning for early lung cancer identification using routine clinical and laboratory data. Am J Respir Crit Care Med, 2021; 204(4):445–453; doi: 10.1164/rccm.202007-2791OC
42.
WuYT, ZhangCJ, MolBW, et al.Early prediction of gestational diabetes mellitus in the Chinese Population via advanced machine learning. J Clin Endocrinol Metab, 2021; 106(3):e1191–e205; doi: 10.1210/clinem/dgaa899
43.
WeiR, QiuH, XuJ, et al.Expression and prognostic potential of GPX1 in human cancers based on data mining. Ann Transl Med, 2020; 8(4):124; doi: 10.21037/atm.2020.02.36
44.
SeoGJ, KimC, ShinWJ, et al.TRIM56-mediated monoubiquitination of cGAS for cytosolic DNA sensing. Nat Commun, 2018; 9(1):613; doi: 10.1038/s41467-018-02936-3
45.
SunX, OuZ, XieM, et al.HSPB1 as a novel regulator of ferroptotic cancer cell death. Oncogene, 2015; 34(45):5617–5625; doi: 10.1038/onc.2015.32
46.
ChenH, ZhengC, ZhangY, et al.Heat shock protein 27 downregulates the transferrin receptor 1-mediated iron uptake. Int J Biochem Cell Biol, 2006; 38(8):1402–1416; doi: 10.1016/j.biocel.2006.02.006
47.
YangM, ChenP, LiuJ, et al.Clockophagy is a novel selective autophagy process favoring ferroptosis. Sci Adv, 2019; 5(7):eaaw2238; doi: 10.1126/sciadv.aaw2238
48.
DunsmoreG, RoseroEP, ShahbazS, et al.Neutrophils promote T-cell activation through the regulated release of CD44-bound Galectin-9 from the cell surface during HIV infection. PLoS Biol, 2021; 19(8):e3001387; doi: 10.1371/journal.pbio.3001387
49.
PulliamL, ListonM, SunB, et al.Using neuronal extracellular vesicles and machine learning to predict cognitive deficits in HIV. J Neurovirol, 2020; 26(6):880–887; doi: 10.1007/s13365-020-00877-6
50.
BisasoKR, KarungiSA, KiraggaA, et al.A comparative study of logistic regression based machine learning techniques for prediction of early virological suppression in antiretroviral initiating HIV patients. BMC Med Inform Decis Mak, 2018; 18(1):77; doi: 10.1186/s12911-018-0659-x
51.
RidgwayJP, LeeA, DevlinS, et al.Machine learning and clinical informatics for improving HIV care continuum outcomes. Curr HIV/AIDS Rep, 2021; 18(3):229–236; doi: 10.1007/s11904-021-00552-3
52.
YoungSD, YuW, WangW. Toward automating HIV identification: Machine learning for rapid identification of HIV-related social media data. J Acquir Immune Defic Syndr, 2017; 74(Suppl. 2):S128–S131; doi: 10.1097/qai.0000000000001240
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
